Several important updates are in regard to Molina Healthcare (MOH). The company continues to outperform its medical peers within the year. BNP Paribas Financial Markets have increased their stake in the healthcare company. The company exceeded expectations with their Q1 2024 earnings , showing growth despite some earnings estimates decreasing from Zacks Research Brokers. However, some traders sold their shares, including Director Richard Schapiro and CFO Mark Keim. Regardless, shares have continued to rise, recently hitting a 52-week high. The future growth is promising with expected rise due to strategic decisions. With a forecasted earnings of $5.64 per share in Q2 2024, the healthcare company is undervalued by 37% according to an intrinsic calculation. The company is also closing successful deals, such as cutting terms for the acquisition of Bright HealthCare's California Medicare Business and securing a major contract via its Michigan subsidiary. The company just announced first quarter results for 2024, and while revenues beat expectations, the EPS lagged.
Molina Healthcare MOH News Analytics from Fri, 30 Jun 2023 07:00:00 GMT to Thu, 16 May 2024 18:07:08 GMT - Rating 8 - Innovation -3 - Information 7 - Rumor 0
